Subsidies provided by a medical device manufacturer to cover the cost-sharing obligations incurred by Medicare beneficiaries participating in a clinical trial of the company’s product would not pose a risk of fraud or abuse that could result in the imposition of sanctions under the Anti-Kickback Statute or the Beneficiary Inducements CMP, the Department of Health and Human Ser... Read More